Codeine and opioid metabolism: implications and alternatives for pediatric pain management

Vidya Chidambaran1, Senthilkumar Sadhasivam, Mohamed Mahmoud

  • 1Department of Anesthesiology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, USA.

Insights

Pediatric perioperative pain management faces challenges with opioid use, especially codeine, due to genetic factors like CYP2D6. Understanding pharmacogenetics can improve opioid selection and safety in children.

Area of Science:

  • Pediatric Anesthesiology
  • Pharmacogenetics
  • Pain Management

Background:

  • Perioperative opioid use in children poses risks, including respiratory depression, particularly in those with obstructive sleep apnea.
  • Adverse events like respiratory depression and death have been reported with codeine in pediatric patients post-tonsillectomy.

Purpose of the Study:

  • To review factors and genetic polymorphisms influencing opioid metabolism and postoperative outcomes in children.
  • To explore the impact of pharmacogenetics on pediatric perioperative pain management.

Main Methods:

  • Literature review of current knowledge on opioid metabolism and adverse effects in children.
  • Analysis of case reports and advisories concerning codeine use in pediatrics.
  • Discussion of alternative pain management strategies.

Main Results:

  • Cytochrome P450 family 2 subfamily D type 6 (CYP2D6) pharmacogenetics is a key factor in codeine metabolism and associated risks.
  • Increased reports of severe adverse events linked to codeine use in children, prompting organizational advisories.
  • Evaluation of alternative analgesics to codeine for pediatric pain relief.

Conclusions:

  • Pharmacogenetics, specifically CYP2D6, holds potential for guiding perioperative opioid selection and dosing in children.
  • Personalized opioid use based on genetic profiling is a future goal for enhancing pediatric pain management safety and efficacy.
Abstract

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.3K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.3K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.5K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
303
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.3K
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
93